Back to search

Article

Cross-sectional study of plasma phosphorylated Tau 217 in persons without dementia

2024-05-17

Abstract excerpt

<h4>Importance</h4> Blood levels of phosphorylated tau 217 (p-tau217) as measured by commercially available immunoassays are an emerging tool to assess Alzheimer’s disease (AD) pathology. Little is known about the performance of p-tau217 and contributors to its variability in aged individuals without AD. <h4>Objective</h4> To determine plasma p-tau217, its associations with age, sex, education and genetic risk,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eac1f33e-470c-5eab-9a19-9c974c1227aa
DOI
10.1101/2024.05.17.24307528
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cross-sectional study of plasma phosphorylated Tau 217 in persons without dementiaDOI 10.1101/2024.05.17.24307528
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsSemantic proximity
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease StagesSemantic proximity
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.Semantic proximity
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progressionSemantic proximity
Robustness of plasma p-Tau217 diagnostic thresholds for Alzheimer’s disease across various clinical populations and laboratory environmentsSemantic proximity
Plasma biomarkers predict amyloid conversion and cognitive decline in cognitively unimpaired adultsSemantic proximity
Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adultsSemantic proximity
Analytical and Clinical Validation of a High Accuracy Fully Automated Digital Immunoassay for Plasma Phospho-Tau 217 for Clinical Use in Detecting Amyloid PathologySemantic proximity
The Alzheimers Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studySemantic proximity
APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrationsSemantic proximity
Pittsburgh plasma p-tau217: classification accuracies for autosomal dominant and sporadic Alzheimer’s disease in the communitySemantic proximity
Genetic architecture of plasma pTau217 and related biomarkers in Alzheimer's disease via genome-wide association studies.Semantic proximity
Select a neighboring publication to make it the new centre.